Author:
Yi-Shin Kuo D.,Timmins Patrick,Blank Stephanie V.,Fields Abbie L.,Goldberg Gary L.,Murgo Anthony,Christos Paul,Wadler Scott,Runowicz Carolyn D.
Subject
Obstetrics and Gynaecology,Oncology
Reference30 articles.
1. Thalidomide: a review of approved and investigational uses;Matthews;Clin. Ther.,2003
2. New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12;Masiero;Angiogenesis,1997
3. Thalidomide;Franks;Lancet,2004
4. Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis;McCarty;Med. Hypotheses,1997
5. Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study);Sutton;Am. J. Obstet. Gynecol.,1989
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献